# Piperacllin Versus Placebo in Patients Undergoing Surgery for Acute Cholecystitis

> **NCT02619149** · PHASE3 · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 100 (actual)

## Conditions studied

- Cholecystitis, Acute

## Interventions

- **DRUG:** Piperacillin-tazobactam combination product
- **DRUG:** Saline solution

## Key facts

- **NCT ID:** NCT02619149
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2017-12
- **Final completion:** 2018-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2018-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02619149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02619149, "Piperacllin Versus Placebo in Patients Undergoing Surgery for Acute Cholecystitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02619149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*